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In recent decades, metabolic syndrome has become a public health problem throughout the world. Longitudinal
studies in humans have several limitations due to the invasive nature of certain analyses and the size and
randomness of the study populations. Thus, animal models that are able to mimic human physiological responses
could aid in investigating metabolic disease. Thus, the present study was designed to analyze metabolic syndrome
markers in albino Wistar rats (Rattus norvegicus) of different ages. The following parameters were assessed at two
(young), four ( adult), six (adult), and twelve (mature) months of age: glucose tolerance (glucose tolerance test);
insulin sensitivity (insulin tolerance test); fasting serum glucose, triglycerides, total cholesterol, HDL cholestero, and
LDL cholesterol concentrations; glucose uptake in isolated soleus muscle; and total lipid concentration in
subcutaneous, mesenteric, and retroperitoneal adipose tissue. We found that aging triggered signs of metabolic
syndrome in Wistar rats. For example, mature rats showed a significant increase in body weight that was associated.
In addition, mature rats showed an increase in the serum concentration of triglycerides, total cholesterol, and LDL
cholesterol, which is characteristic of dyslipidemia. There was also an increase in serum glucose compared with the
younger groups of animals. Therefore, aging Wistar rats appear to be an interesting model to study the changes
related to metabolic syndrome.
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Metabolic syndrome is characterized by a combination
of risk factors for cardiovascular disease and diabetes
that are generally linked to insulin resistance and central
obesity [1]. Cardiovascular disease is the leading cause of
morbidity and mortality in the world [2]; therefore, the
study of metabolic syndrome as a predictor of cardiovas-
cular problems is critical.
Aging correlates with an increase in the prevalence of
cardiovascular disease, which is a health concern, espe-
cially because of increases in the life expectancy of the
world population. The aging of the world population has
caused concerns about the balance of the age pyramid.
Studies have estimated that the proportion of people
over 65 years of age, which was 5.2 % in 1950, will in-
crease to 15.6 % in 2050; thus, the elderly will represent
one fifth of the world population [3].* Correspondence: carolghezzi@gmail.com
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reproduction in any medium, provided the orThe prevalence of metabolic syndrome in the popula-
tion of the United States is 20-25 % and close to 55 %
for the elderly [4]. In Brazil, a metabolic syndrome
prevalence of 52.3 % was observed in the elderly; how-
ever, due to different definitions for metabolic syndrome,
the prevalence may differ among studies [3].
The most commonly used definition for metabolic syn-
drome is the one given by the World Health Organization
(WHO), which requires the presence of diabetes or insulin
resistance and two of the following characteristics: a high
waist/hip ratio, a high concentration of triglycerides or a
low concentration of HDL cholesterol, increased blood
pressure and urinary excretion of albumin [5].
Research using animal models that develop a complete
case of metabolic syndrome, including all of the above
mentioned risk factors, are rare. Studies have demon-
strated that the Wistar Ottawa Karlsburg (WOKW) line
of rats develops a complete case of metabolic syndrome
that includes obesity, moderate hypertension, dyslipide-
mia, glucose intolerance, and hyperinsulinemia [6].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of metabolic syndrome symptoms in rodents is the aging
process; however, manifestation differs between rat
strains. For example, the Fisher 344 rat, which has been
widely used in studies that separately assess metabolic
syndrome characteristics [7], shows a small increase in
body weight at 24 months of age. In this strain, adipocyte
size is markedly increased, and plasma insulin concentra-
tions are slightly higher in mature rats. Wistar rats at
twenty-four months of age show similar blood insulin
levels as adult rats at three months [8] despite the large
increase in body weight and adipocyte hyperplasia [9].
Wistar rats also show a decrease in peripheral glucose
uptake [10] as they age. Furthermore, recent studies have
emphasized that the conditions considered as “standard”
for the general maintenance of laboratory rodents (e.g.,
collective cages containing two to five animals per cage,
with a flooring of wood shavings and free access to food)
could favor the development of metabolic syndrome.
This phenomenon could make rodent models suitable
models of human obesity [11].
Relatively few studies have simultaneously monitored
the development of various metabolic syndrome mar-
kers resulting from aging in Wistar rats, which have
been widely used in experiments in Brazil and in several
different studies conducted by our research group [12-
14]. Therefore, the present study was designed to
analyze metabolic syndrome markers in albino Wistar
rats (Rattus norvegicus) at different ages.
Materials and methods
Animals
The present study used albino Wistar rats between two
and twelve months of age. The rats were obtained from
the central animal facility of São Paulo State University -
UNESP – Botucatu, São Paulo, Brazil and were kept in the
animal facility of the Department of Physical Education of
the São Paulo State University – UNESP – Rio Claro, São
Paulo, Brazil. The rats were fed a standard, balanced ro-
dent diet LABINA (PurinaW, Composition: a control diet
(57,3 % carbohydrate, 41,2 % of cornstach), 200 g protein,
70 g lipids, 50 g fiber, minerals and vitamins are balanced
to the species) and water ad libitum and were kept in col-
lective plastic cages (four per cage) at a room temperature
of 25°C and a 12-h light/12-h dark cycle. The protocol for
the animal studies was subjected to the Ethics Committee
on Animal Use from the Institute of Biosciences, UNESP,
Rio Claro (CEUA), under protocol 2638.
Experimental design and groups
The rats were assessed for metabolic syndrome markers
at different ages:
group 2 months (n = 8) – at two months (young adult);
group 4 months (n = 8) – at four months (adult);group 6 months (n = 8) – at six months (adult);
group 12 months (n = 8) – at twelve months (mature).
Assessment prior to sacrifice
 General assessments:
All animals had their body weight, nasoanal length
and food intake recorded each week. The food in-
take was calculated per cage, using the formula:
Food intake ¼ Daily Food Intake gramsð ÞP
body weight of the rats in each cage gramsð Þ
 Oral glucose tolerance test – OGTT:
The glucose tolerance of the rats was assessed by the
oral glucose tolerance test (OGTT). This test was per-
formed during the last week of the experiment after
12 h of fasting and began when the first blood sample
was taken from a cut at the tip of the tail (time 0). Sub-
sequently, a 20 % glucose solution (2 g/kg body weight)
was administered to the rats via a polyethylene gastric
tube. Blood samples were collected after 30, 60, and
120 min with heparinized capillary tubes, and 25-μL
aliquots were used to determine the glucose and insu-
lin concentrations. A single cut at the tip of the tail
was enough to collect all of the blood samples. Blood
glucose concentrations were determined using the glu-
cose-oxidase method, and insulin concentrations were
determined using commercial enzyme-linked immuno-
sorbent assay (ELISA) kits (LABORLABW). The results
were analyzed with ORIGIN software by calculating
the area under the curve (AUC) for serum glucose and
insulin using the trapezoidal method test [15].
 Insulin tolerance test - ITT
Peripheral insulin sensitivity was assessed by the insu-
lin tolerance test (ITT), which was carried out 48 h
after the OGTT. After the ITT, a crystalline insulin so-
lution (30 IU/100 g body weight, LILLY) was adminis-
tered subcutaneously. Blood samples were collected
after 30, 60, and 120 min with heparinized capillary
tubes, and 25-μL aliquots were used to determine the
concentration of glucose by the glucose-oxidase
method. A single cut at the tip of the tail was enough
to collect all of the blood samples. The glucose removal
rate (KITT), which was expressed as %/minute, was
calculated using the following formula: (0.0693/t/2) x
100. Using ORIGIN software, blood glucose (t/2) was
calculated by the least squares curve analysis for blood
glucose content from the moments when serum glu-
cose decreased after insulin administration [16].
 Animal sacrifice and collection of the biological
material
When the rats reached a predetermined age, they
were all sacrificed by decapitation under deep
anesthesia with CO2 (i.e., 48 h after the last in vivo
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serum separation for glucose, triglycerides, total
cholesterol, LDL cholesterol, and HDL cholesterol
concentrations determination by calorimetric meth-
ods using commercial kits (LABORLAB).
 Soleus muscle
Longitudinal muscle slices weighing approximately
25–35 mg were incubated in Krebs-Ringer bicarbonate
buffer enriched with glucose (5.5 mM). The buffer con-
tained [3H]-2-deoxyglucose (2-DG, 0.5 μCi/mL) and
insulin (100 mU/mL), and the slices were incubated in
glass flasks for approximately 1.5 h under continuous
gassing with carbogen (O2/CO2 ratio of 95 %/5 %) and
constant stirring in a water bath (37°C). Glucose up-
take was assessed using 2-DG as a marker and measur-
ing the radioactivity of [3H] using a beta counter.
 Adipose tissue
The adipose tissue from the posterior subcutaneous,
mesenteric and retroperitoneal were analyzed. Mes-
enteric and retroperitonial are visceral regions of
the adipose tissue, they usually are used as markers
of visceral adiposity.The excision of different fatA
C
Figure 1 The mean and standard deviation for body weight (A) and n
differences are expected in this range. Different letters mean different resuldeposits was performed according to methods
described by Cinti [17]. Data were expressed as a
relation between regional adipose tissue weight
(grams)/body weight (100 grams).
Statistics
The results were statistically analyzed using analysis of
variance (ANOVA) with a pre-established significance level
of 5 %. When needed, the Newman-Keuls post hoc test
was used.
Results
Figure 1 A, B and C show the increase in body weight,
nasoanal length and food intake of the rats. Significant
differences were observed in body weight and nasoanal
length between two and four months of life. Additional
significant increases in body weight and nasoanal length
occurred from six to twelve months. For the figure we
see that food intake to two months the animals eat more
(g/100 g) and two months after intake decreases consid-
erably, reaching an almost stable, with little fluctuation
has one month to another.B
asoanal length (B) from groups containing eight rats each. All
t. (One-way ANOVA and Newman-Keuls post hoc test, P< 0.05).
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before and 30, 60, and 120 min after the glucose load
and for the area under the curve of the blood glucose
during the oral glucose tolerance test (OGTT). There
were no statistical differences between the groups.
Figure 3, A and B show the blood glucose concentra-
tions values before and 30, 60, and 120 min after exogen-
ous insulin administration and the glucose removal
constant (KITT) values during the insulin sensitivity test
(ITT). There were no significant differences between the
groups.
The values for the serum concentrations of glucose,
triglycerides (mg/dL), total cholesterol, HDL cholesterol,
and LDL cholesterol at the end of the experiment are
shown in Table 1. Significant increases in serum glucose,
triglycerides, total cholesterol, HDL cholesterol, and LDL
cholesterol concentrations were observed in twelve-
month-old rats compared with the other age groups.
Table 2 shows the data for the total lipids from the mes-
enteric, retroperitoneal, and subcutaneous regions. A sta-
tistically significant difference was observed between
groups for mesenteric and retroperitoneal regions. The
two-month group had less fat accumulation in all regions
than the other groups, whereas the twelve-month group
had greater accumulation only in the mesenteric region.
Figure 4 presents the glucose uptake values for the iso-
lated soleus muscle. There were no significant differences
between the groups.
Discussion
This study analyzed the effects of aging on the develop-
ment of several metabolic syndrome markers in Wistar
rats, which are often used in research, especially in Brazil.A
Figure 2 The mean and standard deviation for the blood glucose valu
during the oral glucose tolerance test (OGTT). Each group consisted o
between the groups (one-way ANOVA, P> 0.05).The life expectancy of the world population has
increased due to several factors, such as developments in
medicine and improvements in basic sanitation. Longev-
ity, however, is accompanied by several diseases. One
condition that has attracted a lot of attention is meta-
bolic syndrome because the prevalence of cases in the
world population has increased exponentially [18]. Meta-
bolic syndrome is association clinical signs of diseases
that increase the risk of cardiovascular disease, which is
the leading cause of death in the world.
Because of the relationship between metabolic syn-
drome and cardiovascular disease, there is a need to
understand the mechanisms of metabolic syndrome.
Thus, several studies have been conducted with experi-
mental models because the analysis of metabolic syn-
drome mechanisms often includes invasive procedures,
which are restricted from being used in humans. Mag-
netic resonance spectroscopy in humans provides a non
invasive way to measure fat, glucose and glycogen in
humans and rodents, and many such studies show such
longitudinal and dynamic measures can successfully be
made [19].Rats and mice are among the animals most
commonly used to study metabolic syndrome, and sev-
eral rodent strains have been used.
The present study used albino Wistar rats and found
that the rats in the two-month group had lower body
weights compared with the other groups. The rats
shows a marked gain in body weight from two to four
months due to their stage of growth and development.
Although body weight stabilized from four to six
months, there was another significant weight increase
at twelve months. A similar result has also been
observed by Lerco et al. [20] a in Wistar rats. TheB
es and the area under the curve of the blood glucose values
f eight rats. Note: There were no statistically significant differences
A B
Figure 3 The mean and standard deviation for the blood glucose and the glucose removal constant (KITT) values during the insulin
sensitivity test (ITT). Each group consisted of eight rats. Note: There were no statistically significant differences between the groups (one-way
ANOVA, P> 0.05).
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there is stabilization of food intake, which agrees with
literature data [21,22]. Similar to human beings, rats
ate more during accelerated body growth with subse-
quent stabilization. These data indicate that increasing
the weight gain of animals and an increase of mesen-
teric fat is not related to the increased food intake.
Ford et al. [4] used criteria defined by the NCEP and
found that the prevalence of both obesity and metabolic
syndrome in humans increases with age.
The results of the OGTT and ITT at two, four, six, and
twelve months of age demonstrated that there was no
change in the blood glucose level throughout the experi-
mental period (i.e., neither glucose tolerance nor insulin
sensitivity were affected). These findings were in agreement
with previous studies that reported that Wistar rats at
twenty-four months of age have similar blood insulin and
blood glucose levels as three-month-old adult rats [8] des-
pite increases in body weight and adipocyte hypertrofy [9].
Metabolic syndrome comprises several physiological dis-
orders and those changes also affect the glucose transpor-
ters, regulation of homeostasis intra and extra-cellularTable 1 The means and standard deviations for the serum co
total cholesterol (mg/dL), HDL cholesterol (mg/dL), and LDL c
Age Glucose Triglycerides
2 months 98 ± 14a 105 ± 30a
4 months 109 ± 8a 100 ± 11a
6 months 119 ± 29a 125 ± 33a
12 months 152 ± 29b 260 ± 83b
Different letters indicate a statistically significant difference (one-way ANOVA and Nglucose is directly related to controlling the expression of
genes that encode different glucose transporters [23]. The
stimulation of insulin causes the translocation of GLUT4
to happen toward the plasma membrane thereby increas-
ing glucose uptake, participating significantly in the con-
trol of glucose homeostasis [24].
At twelve months, the blood biochemistry of the rats
showed an increase in the levels of triglycerides, total chol-
esterol, and LDL cholesterol, which was characteristic of
the onset of dyslipidemia. Interestingly, Mota et al. reported
different results [12]; however, their animals were assessed
for a shorter period of time (i.e., from weaning to 120 days
of age), which could explain the difference between the
present study and the study by Mota et al. [12]. The main-
tenance of high-circulating triglycerides concentration
causes an imbalance in lipid and carbohydrate oxidation
[25]. This phenomenon can increase plasma glucose, as
observed in the present study was an increase in blood glu-
cose at twelve months compared with the younger age
groups. Interestingly, studies of mature diabetic patients
have shown that these individuals have a higher risk to de-
velop dyslipidemia than nondiabetic individuals [26].ncentrations of glucose (mg/dL), triglycerides (mg/dL),
holesterol (mg/dL) (n = 8 per group)
Total Cholesterol HDL LDL
82 ± 7a 29 ± 8a 64 ± 8a
100 ± 10a 48 ± 4a 67 ± 3a
100 ± 8a 40 ± 6a 63 ± 8a
171 ± 30b 79± 25b 121 ± 19b
ewman-Keuls post hoc test, P< 0.05).
Table 2 The means and standard deviations of total lipids
(mg/100 g) in the adipose tissue from different regions
(n = 8 per group)
Groups Mesenteric Retroperitoneal Subcutaneous
2 months 1 005 ± 240a 770 ± 212a 692 ± 177a
4 months 2 267 ± 726b 2634 ± 536 b 1 851 ± 403b
6 months 2475 ± 537b 2472 ± 408b 1 499 ± 381b
12 months 4399 ± 643c 3191 ± 703b 1 896 ± 758b
Different letters indicate a statistically significant difference (one-way ANOVA
and Newman-Keuls post hoc test, P< 0.05).
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bolic syndrome is visceral fat. Fat distribution is
reported to be more closely linked to metabolic dis-
orders than total body weight, and fat distribution is
even more significant in older individuals [27] There-
fore, central body fat is a more reliable factor in the
diagnosis of metabolic syndrome and other morbid-
ities than the classification of the degree of obesity.
Importantly, visceral fat is closely linked with the de-
velopment of insulin resistance and other glucose
alterations disorders.
Because glucose is an important substrate for muscles,
it is of value to investigate the muscle metabolism of
this substrate during the aging process in Wistar rats.
Thus, the present study assessed glucose uptake in incu-
bated soleus muscle. Interestingly, there were no statis-
tically significant differences between the groups. These
data can reveal the cause-effect order in the metabolic
syndrome markers.Figure 4 The mean and standard deviation for the glucose
uptake (μmol/g/h) by the isolated soleus muscle. Each group
consisted of eight rats. Note: There were no statistically significant
differences between the groups (one-way ANOVA, P> 0.05).As described before, the lipid metabolism was altered;
this change can lead to future alterations in the carbohy-
drate metabolism [28]. The twelve month group showed
higher concentration of serum glucose compared to the
younger. This can be the first metabolic alteration found.
Studies from our laboratory [29,30] using fructose to in-
duce metabolic syndrome in rats, have demonstrated
that the alterations in the lipid metabolism are more evi-
dent than glucose alterations.
Studies have shown that aging causes the spontaneous
development of obesity and insulin resistance in rats. In
addition, some studies have reported changes in glucose
transporter type 4 (GLUT 4) content in mature rats;
however, these studies used different rat strains and ana-
lyzed different muscles [31].
Conclusion
The aging process triggered metabolic syndrome charac-
teristics in Wistar rats. Mature rats showed a significant
increase in body weight and lipid content in adipose tis-
sue. In addition, mature rats showed characteristics of
dyslipidemia, such as increased serum triglycerides, total
cholesterol, and LDL cholesterol. Similarly, mature rats
showed an increase in serum glucose compared with
younger groups. Therefore, aging Wistar rats appear to
be an interesting model for the study of the changes
related to metabolic syndrome.
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